DrugPatentWatch Database Preview
US Patent Family Members and Approved Drugs for China Patent: 104968625
» See Plans and Pricing
US Patent Family Members and Approved Drugs for China Patent: CN104968625
US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
---|---|---|---|---|
Start Trial | 2031-10-25 | insulin recombinant human | Lilly | HUMULIN R |
Start Trial | 2031-10-25 | insulin human | Lilly | HUMULIN R KWIKPEN |
Start Trial | 2031-10-25 | insulin human | Lilly | HUMULIN R |
Start Trial | 2031-10-25 | insulin recombinant human | Lilly | HUMULIN R PEN |
>US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |